Express Pharma

JUNE 22, 2023

The healthcare industry continues to face the challenges such as persistent inflation in a post-COVID-19 world. Healthcare professionals (HCPs) believe that biosimilars could provide costs savings for the patients and healthcare systems and their use should be encouraged, according to a survey by GlobalData.

Biosimilars 89

Biosimilars 89

Express Pharma

MAY 6, 2024

China, India, and South Korea among the top three countries The Asia-Pacific (APAC) region is leading in clinical trials in Asthma, with China, India, and South Korea among the top countries in this space, according to GlobalData. According to GlobalData’s Clinical Trials Database, during 2019-23, 51.8

85

85

Express Pharma

JANUARY 8, 2024

Hoverer, the post-pandemic slump is expected to end with the market heading to recovery in 2024, finds GlobalData. Urte Jakimaviciute, Senior Director of Market Research at GlobalData, comments, “Biotech’s funding and investors are faced with current market uncertainty with high inflation, high interest rates, and geopolitical challenges.

Pharmaceutical Companies 93

Pharmaceutical Companies Pharmaceutical Companies Drug Development 93

Express Pharma

DECEMBER 28, 2023

Healthcare industry professionals scored cell and gene therapy (CGT) as the industry trend to have the greatest impact on the pharmaceutical industry in 2024, in a recent survey launched by GlobalData. According to GlobalData estimates, the global CGT market is projected to reach $80 billion by 2029.

Drug Development 96

Drug Development 96

Express Pharma

MARCH 5, 2024

Cell and gene therapies (CGTs) have been gaining traction within the medical community as treatment options that are expected to replace lifelong management of chronic diseases with fewer number of doses, which could offer significant benefits for both patients and strained healthcare systems.

105

105

Express Pharma

JULY 12, 2023

With a growing focus on data-driven healthcare, GenAI is poised to significantly transform the industry, says GlobalData Kiran Raj, Practice Head, Disruptive Tech, GlobalData comments, “GenAI is fundamentally revolutionising the healthcare scene, powering a transformative shift across the value chain.

Communication 83

Communication 83

Express Pharma

FEBRUARY 21, 2024

The focus is on introducing new molecular entities (NMEs) into India, with both parties contributing to accelerate commercialisation and address evolving healthcare needs, finds GlobalData. The post India pharma giants and global big pharma join forces for NMEs commercialisation in India: GlobalData appeared first on Express Pharma.

92

92

Express Pharma

FEBRUARY 29, 2024

Leriglitazone is a promising treatment that can be of greater accessibility to patients and healthcare providers, with significantly reduced costs compared to an intravenously administered hematopoietic stem cell transplantation (HSCT), says GlobalData.

94

94

Express Pharma

MARCH 12, 2024

Healthcare professionals globally express cautious optimism, emphasising the importance of alternative funding avenues and industry partnerships. This dynamic landscape sets the stage for potential growth and innovation in the biotech sector, says GlobalData. per cent and 52.3 per cent compared to 2022 and 2021 respectively.

100

100

Express Pharma

MARCH 31, 2024

While cooperation between APAC-based pharmaceutical companies and their global counterparts has been on the rise, active cooperation among pharma companies within the APAC region is gaining traction, observes GlobalData. The post Active cooperation among APAC pharma companies gaining traction: GlobalData appeared first on Express Pharma.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceutical Companies 100

Express Pharma

DECEMBER 28, 2023

However, a major obstacle to effectively combating rare diseases in India is the lack of awareness and inadequate diagnosis in the country, says GlobalData. Jithendra Kancharla, Pharma Analyst at GlobalData, comments, “Rare diseases, by definition, afflict a small number of individuals in a population.

Diabetes 92

Diabetes 92

Express Pharma

MAY 13, 2024

With other pharmaceutical companies entering the race for developing the first marketed therapy against bronchiectasis, the great opportunity in the market is underlined, says GlobalData , a data and analytics company.

Pharmaceutical Companies 80

Pharmaceutical Companies Pharmaceutical Companies Labelling 80

Express Pharma

JANUARY 22, 2024

The development of new weight loss medicines is therefore making great progress, but obesity care needs a much greater revolution, says GlobalData. Costanza Alciati, Pharma Analyst at GlobalData, comments, “Obesity was previously considered a lifestyle choice to be corrected with diet and exercise.

111

111

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 113% rise in company filings mentions of cybersecurity in Q1 2023 compared with the previous quarter, with the highest share accounted for by Alnylam Pharmaceuticals with 114% year-on-year increase, according to GlobalData’s analysis of over 667 pharmaceutical company filings.

Pharmaceutical Companies 81

Pharmaceutical Companies Pharmaceutical Companies 81

Express Pharma

MAY 14, 2024

billion, with a 71 per cent year-on-year (YoY) increase of mega deals that were valued at $1 billion or more compared to Q1 2023, reveals GlobalData, a leading data and analytics company. In Q1 2024 alone, biopharmaceutical M&A reached a total deal value of $43.5

Pharmaceutical Companies 70

Pharmaceutical Companies Pharmaceutical Companies 70

Express Pharma

JANUARY 12, 2024

The market still lacks therapeutics that provide better safety, says GlobalData. Key opinion leaders (KOLs) interviewed by GlobalData have expressed the opinion that some women are hesitant to take hormonal contraceptives because of the associated side effects.

96

96

Express Pharma

NOVEMBER 16, 2023

per cent between 2023 and 2029, according to GlobalData forecasts. To reduce Casgevy’s costs and ensure its safety and effectiveness, ongoing research, ethical oversight, and collaboration among scientists, policymakers, and healthcare providers are imperative.” The US FDA is currently considering approval of Casgevy for SCA.

Compounding 59

Compounding 59

Pharmaceutical Technology

MAY 9, 2023

The global pharmaceutical industry experienced a 113% rise in company filings mentions of cybersecurity in Q1 2023 compared with the previous quarter, with the highest share accounted for by Alnylam Pharmaceuticals with 114% year-on-year increase, according to GlobalData’s analysis of over 667 pharmaceutical company filings.

Pharmaceutical Companies 75

Pharmaceutical Companies Pharmaceutical Companies 75

Express Pharma

MARCH 6, 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) approved Vertex ’s exagamglogene autotemcel (Casgevy) in late 2023. The precision of CRISPR technology makes it an appealing option for oncology therapeutics, presenting a revolutionary approach to cancer treatment, says GlobalData.

Immunity 108

Immunity Immunization 108

Express Pharma

NOVEMBER 23, 2023

It serves as an important reminder that sectors such as healthcare, agriculture, and waste management all have a crucial role to play in mitigating the impacts of AMR. It also highlights that key priorities should include improved antimicrobial stewardship and investment in novel therapies, says GlobalData.

Drug Development 103

Drug Development 103

Pharmaceutical Technology

MAY 11, 2023

The global pharma industry experienced a 32% rise in social media posts on artificial intelligence in Q1 2023 compared with the previous quarter, with the highest share accounted for Healthcare Information and Management Systems Society, according to GlobalData’s analysis of social media posts.

52

52

Pharmaceutical Technology

JUNE 12, 2023

The global pharmaceutical industry experienced a 149% rise in company filings mentions of cloud in Q1 2023 compared with the previous quarter, with the highest share accounted for by Pfizer with 14% year-on-year decrease, according to GlobalData’s analysis of over 140 pharmaceutical company filings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

DECEMBER 7, 2023

The measures initiated by Madrigal for the launch are expected to set the tone for future launches of NASH therapies by other small companies, according to GlobalData. The post Madrigal’s efforts for resmetirom will set tone for future launches of NASH therapies: GlobalData appeared first on Express Pharma.

102

102

Pharmaceutical Technology

NOVEMBER 25, 2022

Artificial intelligence (AI) was seen as one of the top current investment priorities and was thought to continue to attract investment in the healthcare sector in the upcoming two years, according to GlobalData's latest report ‘Digital Transformation and Emerging Technology in the Healthcare Industry - 2022 Edition’.

Pharmaceutical Companies 145

Pharmaceutical Companies Pharmaceutical Companies 145

Express Pharma

DECEMBER 21, 2023

Costanza Alciati, Pharma Analyst, GlobalData comments, “Weight regain and reversal of cardiometabolic improvements are a huge limitation for all marketed GLP-1R agonists, not only for Zepbound.” per cent of bodyweight by week 120.

Drug Development 97

Drug Development 97

Pharmaceutical Technology

JUNE 12, 2023

The global pharmaceutical industry experienced a 120% rise in company filings mentions of internet of things in Q1 2023 compared with the previous quarter, with the highest share accounted for by Moderna, according to GlobalData’s analysis of over 61 pharmaceutical company filings. Starting at 100 in 2020, an index over 100 is more positive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Express Pharma

OCTOBER 17, 2023

Currently, the only FDA-approved DC vaccine, Dendreon’s Provenge, did not make a lasting impact, indicating significant developmental challenges for DOC1021 and other agents using a DC-based platform, according to GlobalData. DC-based tumor vaccines, such as DOC1021, present a potential innovative treatment. months longer than placebo.

Vaccines 94

Vaccines Immunity Immunization 94

Pharmaceutical Technology

MAY 29, 2023

The global pharmaceutical industry experienced a 17% rise in company filings mentions of blockchain in Q1 2023 compared with the previous quarter, with the highest share accounted for by Bayer, according to GlobalData’s analysis of over 60 pharmaceutical company filings. Starting at 100 in 2020, an index over 100 is more positive.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JULY 21, 2022

Listed below are the key technology trends impacting the ESG performance in the healthcare sector, as identified by GlobalData. The healthcare industry is vulnerable to cyberattacks due to the amount of valuable and sensitive data it produces. Artificial intelligence (AI). Cybersecurity and ESG.

Drug Development 98

Drug Development Hospitals 98

Express Pharma

OCTOBER 30, 2023

trillion in Q3 2023, reveals GlobalData. Ophelia Chan, MSc, Business Fundamentals Analyst at GlobalData, comments, “Lilly retained top position as its market capitalisation surpassed $500 billion. The post Top 20 global biopharma cos report marginal growth in market cap during Q3 2023: GlobalData appeared first on Express Pharma.

Drug Pricing 93

Drug Pricing 93

Express Pharma

APRIL 5, 2023

billion in 2031, driven by the launch of therapies with promising efficacies and/or new routes of administration, as well as the growth of the obese population, forecasts GlobalData. Sara Reci, Healthcare Analyst at GlobalData, comments, “Novo Nordisk’s Wegovy has established the efficacy of GLP-1RA therapies for obesity.

Biosimilars 95

Biosimilars 95

Express Pharma

AUGUST 8, 2023

billion in 2032, driven by the launch of therapies with promising efficacies and new mechanism of actions, as well as the growth of the dyslipidemia population, according to GlobalData. bn in 2032 across 7MM: GlobalData appeared first on Express Pharma. per cent from $5.56 billion in 2022 to $15.53

Compounding 87

Compounding Drug Development 87

Pharmaceutical Technology

JULY 19, 2022

All aspects of environmental, social, and governance (ESG) are important, and in the healthcare industry, companies must excel across all three. Listed below are the impact of ESG on healthcare, as identified by GlobalData. The post ESG Top Trends: Healthcare ESG Impact appeared first on Pharmaceutical Technology.

Hospitals 64

Hospitals Vaccines 64

Pharmaceutical Technology

JUNE 6, 2023

The global pharma industry experienced an 11% rise in social media posts on regenerative medicine in Q1 2023 compared with the previous quarter, with the highest share accounted for Pfizer, according to GlobalData’s analysis of social media posts. Buy the report here.

40

40

Express Pharma

JULY 14, 2023

billion in 2032 across the eight major markets (8MM*), due to the patent expiration of the novel oral anticoagulants (NOACs) and the entry of low-cost generics, according to GlobalData. per cent from $14.53 billion in 2022 to $12.8

Compounding 93

Compounding Drug Development 93

Express Pharma

AUGUST 31, 2023

per cent share by 2029, according to GlobalData. Dr Biswajit Podder, Oncology and Hematology Analyst at GlobalData, comments, “mRNA-based therapies have the potential to revolutionize cancer treatment. The post BioNTech to lead $2 bn mRNA-based oncology therapy market despite challenges: GlobalData appeared first on Express Pharma.

Immunity 102

Immunity Immunization Vaccines 102

Express Pharma

AUGUST 1, 2023

Against this backdrop, Cyltezo from Boehringer Ingelheim has shown the intersection of price and regulation in the biosimilar market, says GlobalData. GlobalData’s interviews with key opinion leaders (KOLs) reveals that specialists indicated a lack of concern in transferring patients from Humira to biosimilars in general.

Biosimilars 96

Biosimilars 96